[29P-am351S] Formulating Study of Transdermal Absorbent Gel to improve the feeling of use

○Shino Inoue¹, Ikumi Sugiyama¹, Kaana Ando², Yasuyuki Sadzuka ¹ (1. Sch of Pharm, Iwate Med Univ, 2. Grad. Sch. Pharm, Iwate Med Univ)

[29P-am352] Utility of a novel micro-spraying device for intranasal administration

○Naoto Suzuki¹, Hiroaki Tanigawa¹, Taiki Nagatomo¹, Hiroko Miyagishi², Takanori Kanazawa³, Toyofumi Suzuki¹, Yasuhiro Kosuge² (1. Laboratory of Pharmaceutics, School of Pharmacy, Nihon University, 2. Laboratory of Pharmacology, School of Pharmacy, Nihon University, 3. Graduate School of Biomedical Sciences, Tokushima University)

[29P-am353] Evaluation of dissolution and pharmacokinetics of chitosan combination tablets with excellent disintegration properties

TOMOKI ADACHI¹, YUTO TOMITA¹, KAZUO KAWANO², YASUYUKI MIZUKAI², YUJI MAEZAKI², MASAKI OTAGIRI¹, ○Makoto Anraku¹ (1. Faculty of Pharmaceutical Sciences, Sojo University, 2. Nippon Kayaku Food Techno Co., Ltd.)

[29P-am354] Development of UniORV, a solid formulation containing SMEDDS, to improve the solubility of poorly water-soluble drugs.

Md. Maisum Sarwar Jyoti¹, Misuzu Mineda¹, Syunsuke Sei¹, ○Masaki Okawara¹ (1. Sunsho Pharmaceutical)

[29P-am355S] Influence of fenvalerate and its acetylene derivative on inflammatory response of human keratinocytes

○Ayumi Hiraiwa¹, Midori Oyama¹, Tomoharu Takeuchi¹, Tomoko Kezuka², Tomotaka Mabuchi³, Tomomi Hatanaka^1,3 (1. Fac. Pharm. & Pharm. Sci, Josai Univ, 2. Fac. Eng., Tokai Univ, 3. Sch. Med., Tokai Univ)

[29P-am356S] Preparation and palatability evaluation of gummy formulations of calcium acetate

○Yuma Okamura¹, Sayuri Kawamoto¹, Yuka Yamasaki¹, Motoyasu Miura¹, Yasuharu Kashiwagura¹, Hiroshi Suzuki², Katsuya Yamauchi², Shinya Uchida¹ (1. Sch. Pharm. Sci., Univ. Shizuoka, 2. Yamauchi Pharmacy)

[29P-am357S] Novel glycosylated GLP-2 derivatives translocate neurons by axonal transport in the trigeminal nerve

○Saori Nishimura¹, Haruka Umetani¹, Marina Nakazawa¹, Tomomi Akita¹, Chikamasa Yamashita¹ (1. Dept. Pharm. Sci., Tokyo Univ. Sci)

[29P-am358] Study on dissolution behavior of levofloxacin tablet in simultaneous suspension of kampo medicine containing metal

○toshihisa onoda¹, Hiroyuki Tanaka¹, Toshihiro Ishii¹ (1. Grad. Sch. Pharm. Sci., TOHO Univ.)

[29P-am359] A comparative study of in-hospital ophthalmic liquid preparations between the foreign insoluble matter test and the insoluble particulate matter test using the liquid particle counter

○Shinsuke Hara¹, Keiichiro Higuchi¹, Shunya Yonemura¹, Hiroko Matsui¹, Shinichiro Maeda¹, Masahiro Okuda¹ (1. Department of Pharmacy, Osaka University Hospital)

[29P-am360] Study on Hygroscopicity and Storage of Atorvastatin-Ezetimibe Combination Tablets for Single Dose Package

○TAKANORI NAKAJIMA¹, Reina Otsuka¹, Nanami Noguchi¹, Yusuke Takizawa¹, Takuro Kurita¹ (1. Nihon Pharmaceutical University)

[29P-am361S] Synthesis and Evaluation of Transferrin-Modified Mesoporous Silica Nanoparticles Supporting 5-Fluorouracil Formulation with Active Targeting Capacity

○Yuta Gotou¹, Tomoya Kubo¹, Rina Miyati¹, Miyu Yasufuku¹, Youji Yanakawa¹, Tetuya Nakamura¹ (1. Fac. Pharm. Sci., Fukuyama Univ.)

[29P-am362] Comparison of doses of Dutasteride preparations administered via a nasal feeding catheter using various administration devices used in the simple suspension method

○Shiro Ishida¹, Daiki Kirizume², Kenta Yoshimatsu³, Tetsuaki Ando⁴ (1. Kagawa Sch. Pharm. Sci., Tokushima Bunri Univ., 2. Grad. Sch. Med., Kagawa Univ., 3. Fac. Pharm. Sci., Tokushima Bunri Univ., 4. Pharm., Kibikogen Lumiere Hos.)

[29P-am363S] Experiment study about container size for compounding equal volume mixture of Steroid ointment/crem and Hirudiod® soft ointment using planetary centrifugal mixer

○Hinako Takahashi¹, Honoka Inoue¹, Anna Kiyomi¹, Munetoshi Sugiura¹, Haruka Manabe², Mika Matsumoto³, Michiteru Ohtani³, Taro Ikuta⁴ (1. Department of Drug Safety and Risk Management, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, 2. Department of Hospital Pharmacy, Tokyo Teishin Hospital, 3. Department of Hospital Pharmacy, Kyoundo Hospital, 4. Thinky Corporation)

[29P-am364S] Development of objective tablet coloration evaluation method using color difference values

○Koichi Otaki¹, Motoyasu Miura¹, Hiromu Kikuchi¹, Sayuri Kawamoto¹, Yasuharu Kashiwagura¹, Hiroshi Suzuki², Katsuya Yamauchi², Shinya Uchida¹ (1. Sch. Pharm. Sci., Univ. Shizuoka, 2. Yamauchi Pharmacy)

[29P-am365] Evaluation of changes in workload of pharmacist assistants accompanying the update of an automated injection drug dispensing system

○Ken Tasaka¹, Eri Mizutani¹, Hiroko Matsuda¹, Miki Ishibashi¹, Akiharu Okamoto¹, Rika Mukouhara¹, Takuya Iwamoto¹ (1. Mie University Hospital Department of Pharmacy)

[29P-am366] Benefits to pharmaceutical operations from the introduction of tablet sorting machine TABSORT⁺

○Satoshi Kawakami¹, Kosuke Nishizawa¹, Yudai Kobayashi¹, Naoki Itoi¹, Aya Komine¹, Naoko Sato¹, Hirokazu Doi¹ (1. Dep. Pharm. Toho Univ. Sakura Med. Ctr.)

[29P-am367S] Development of a viable colon delivery capsule for in-hospital fecal transplantation.

○Yuka Matsunaga¹, Atsuo Kuramasu³, Masahiro Hosonuma³, Shino Kuwamura¹, Kiyoshi Yoshimura³, Akihiro Nakamura², Tsutomu Harada² (1. Pharm.,Showa Univ.,, 2. Grad. Sch. Pharm. Sci., Showa Univ., 3. Clin. Res. Inst., Showa Univ.)

[29P-am368S] Evaluation of time-dependent changes in ganciclovir and the degradation products in 2% ganciclovir ophthalmic solution under different storage conditions

○Noriko Shinkai¹, Masayuki Tsujimoto¹, Sana Watanabe¹, Yoko Kado², Kohshi Nishiguchi¹ (1. Kyoto Pharm. Univ.,, 2. Dept. of Pharm., JCHO, Osaka Hosp.,)

[29P-am369] Study of Differences in Physicochemical Properties of Branded and Generic Infusion Fluid: Investigation of Type 2 Hypotonic Infusion Fluids

○Sawako Takei¹, Soh Katsuyama², Yusuke Hori¹ (1. Tokyo University of Pharmacy and Life Sciences, 2. Nihon Pharmaceutical University)

[29P-am370S] Identification of issues related to nutrition using near-miss events from pharmacies

○Mari Maese¹, Shingo Kondo¹, Hiroki Iwata¹, Noriko Kobayashi¹, Katsunori Yamaura¹ (1. Div. Social Pharm, Keio Univ.)

[29P-am371] Study on the passage through feeding tubes of Azithromycin fine granules for children

○Tamaki Imai¹, Chieko Maida¹, Shigeo Akiyama², Etsuko Miyamoto^3,4 (1. Fac.Pharm.Sci.,Hokuriku Univ., 2. Tokyo Univ.Pharm.& Life Sci., 3. NPO HEART, 4. Nijiiro Create Corp.)

[29P-am372] Study on the pass through feeding tubes of Azilsartan tablets in brand name drug and generic drugs

○Aoi Mukozaka¹, Chieko Maida¹, Shigeo Akiyama ², Etsuko Miyamoto^3,4 (1. Fac. Pharm. Sci., Hokuriku Univ., 2. Tokyo Univ. Pharm. & Life Sci., 3. NPO HEART, 4. Nijiiro Create Corp.)

[29P-am373S] Risk of Candida infections associated with total parenteral nutrition

○Maaya Fukumura¹, Yuka Nagatsuka¹, Sayaka Ban², Yuhki Sato¹ (1. Fac. Pharm. Pharmaceut. Sci., Fukuyama Univ., 2. Med. Mycol. Res. Ctr., Chiba Univ. )

[29P-am374S] The effects of semisolid enteral nutrients on gastric tacrolimus absorption in rats

○Chisato Kajihara¹, Yoko Urashima¹, Yuka Suemitsu¹, Goki Morita¹, Kazuya Urashima², Kaoru Suzuki³, Kazumi Kurachi³, Masami Nishihara³, Masashi Neo³, Takuro Kobori¹, Tokio Obata¹ (1. Pharm., Osaka Ohtani Univ., 2. Pharm., JCHO Osaka Minato Center Hosp., 3. Pharm., Osaka Med. and Pharm. Univ. Hosp.)

[29P-am375S] The effect of lipids and metals in enteral nutrients on the gastric carbamazepine absorption

○Yuka Suemitsu¹, Yoko Urashima¹, Aoi Kawaguchi¹, Riyu Kikuchi¹, Chisato Kajihara¹, Goki Morita¹, Kazuya Urashima², Kaoru Suzuki³, Kazumi Kurachi³, Masami Nishihara³, Masashi Neo³, Takuro Kobori¹, Tokio Obata¹ (1. Pharm., Osaka Ohtani Univ., 2. Pharm., JCHO Osaka Minato Center Hosp., 3. Pharm., Osaka Med. and Pharm. Univ. Hosp.)

[29P-am376] Evaluation of the association between hepatic toxicity and age in patients treated with tolvaptan using the spontaneous reporting databases

○Takaya Uno¹, Kouichi Hosomi¹, Satoshi Yokoyama¹ (1. Faculty of Pharmacy, Kindai University)

[29P-am377] Information dissemination efforts that combine the tradition of a women's medicine sales company that has continued since the Edo period with the modern era of women's empowerment

○Tomoko Hiraiwa¹, Mitsutoshi Hirade¹, Katsuhito Kidokoro¹, Tomozumi Kidani¹, Kazuo Kidani¹ (1. Kitani Co.,Ltd.)

[29P-am378] Academic initiative by pharmacists to spread biosimilars -Systematic Review Protocol: Anti-vascular endothelial growth factor biosimilars for macular degeneration-

○Tomiko Sunaga^1,2, Masayuki Maeda³, Andrew Mason⁴, Hisashi Noma⁵, Erika Ota⁶, Takeshi Hasegawa⁷ (1. Showa University Dental Hospital, 2. Department of Hospital Pharmaceutics, School of Pharmacy, Showa University, 3. Division of Infection Control Sciences, Department of Clinical Pharmacy, School of Pharmacy, Showa University, 4. Department of General Education, School of Medicine, Juntendo University, 5. Department of Data Science, The Institute of Statistical Mathematics, 6. Global Health Nursing, St.Luke’s International University, 7. Showa University Research Administration Center (SURAC), Showa University)

[29P-am379S] Analysis of antimicrobial agents induced-convulsion based on the Japanese Adverse Drug Event Report (JADER) database

○Hajime Watanabe¹, Kenji Okada^1,2, Masataka Iwashita¹, Yosuke Kobayashi¹, Takashi Yoshikado¹, Mikako Oka¹, Koji Chiba¹, Yoshihiro Uesawa² (1. Yokohama Univ. Pharm., 2. Meiji Pharm. Univ.)

[29P-am380S] Differences in the safety profiles of metformin and imeglimin

○Yuta Takahashi¹, Rikuto Masuda¹, Masataka Shishido¹, Yoshihiro Noguchi¹, Tomoaki Yoshimura¹ (1. Gifu Pharm. Univ.)

[29P-am381S] Comprehensive analysis of steroidal drugs inducing glaucoma: Insights from the FDA Adverse Event Reporting System (FAERS)

○Ayano Kawabe¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

[29P-am382S] Analysis of taste and smell disorders induced by antineoplastic drugs using the FDA adverse event reporting system (FAERS) database

○Risa Hamazaki¹, Yoshihiro Uesawa¹ (1. Meiji Pharmaceutical University)

[29P-am383S] Analysis of Farnesoid X Receptor Antagonist-Related Adverse Events Based on Machine Learning QSAR Predictions Using the FAERS Database

○Maho Aizawa¹, Yoshihiro Uesawa¹ (1. Meiji Pharm Univ)

[29P-am384S] Efficacy of Bempedoic Acid in Dyslipidemia: a Meta-Analysis of RCTs

○Tatsunobu Kurosawa¹, Akira Kato¹, Akihide Sumino¹, Hideko Sone¹, Kohsuke Hayamizu¹ (1. Yokohama Univ. Pharm.)

[29P-am385] Implementation efforts of hospital formulary

○Kanako Kobayashi¹, Takayuki Inoue¹, Kumi Sutou¹, Sanae Matsumoto¹, Michiyasu Murakami¹ (1. Pharm. Dept., Matsuyama Red Cross Hosp.)

[29P-am386] The profiles of rhabdomyolysis associated with proton pump inhibitor: An analysis of the Japanese Adverse Drug Event Reporting system

○Megumi Iida¹, Katsuhiro Ohyama¹, Shota Akiyama¹, Yusuke Hori¹ (1. Tokyo Univ Pharm and Life Sci )

[29P-am387S] Development of prediction models using the FAERS database to identify drugs that induce anaphylactic reactions

○Kazuna Ozawa¹, Yoshihiro Uesawa¹ (1. Meiji Pharm Univ)

[29P-am388] A study on the confirmation of various neurological side effects in pharmacy pharmacists.

○Koki Wakimura¹, Yuko Sekine¹, Kazuki Nagashima¹, Takao Utsumi¹ (1. Grad. Sch. Pharm. Sci., Chiba Univ.)

[29P-am389S] Comprehensive analysis of appetite-related factors using the FDA Adverse Event Reporting System (FAERS)

○Yukiho Shibuya¹, Yoshihiro Uesawa¹ (1. Meiji Pharm Univ)

[29P-am390S] Analysis of biochemical pathways associated with antineoplastic drug-induced stomatitis using the FDA Adverse Event Reporting System database

○Moena Kagaya¹, Yoshihiro Uesawa¹ (1. Meiji Pharm Univ)

[29P-am391S] Development of a prediction model for identifying drugs inducing depression based on comprehensive analysis of FAERS

○Mizuki Kimura¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

[29P-am392S] Correlation between layer separation and storage temperature in a mixture of clobetasol propionate ointment formulations and heparinoid oil-based cream formulations

○Saki Tanaka¹, Shuji Yamashita², Yoko Ino², Naoki Matsumaru², Akio Suzuki³, Toshiro Fukami⁴, Tatsuo Koide⁵, Hideki Hayashi², Yoshihisa Yamamoto¹ (1. Teikyo-Heisei Univ., 2. Gifu Pharmaceutical Univ., 3. Gifu Univ. Hospital, 4. Meiji Pharmaceutical Univ., 5. National Institute of Health Sciences)

[29P-am393] Structural analysis of levofloxacin OD tablets by low frequency Raman imaging

○Yoshihisa Yamamoto¹, Yutaro Hirose², Naoki Shimada³, Toshiro Fukami³, Tatsuo Koide⁴ (1. Fac. Pharm. Sci., Teikyo Heisei Univ., 2. HORIBA, Ltd., 3. Meiji Pharmaceutical Univ., 4. National Institute of Health Sciences)

[29P-am394] Analysis of the antitumor effects of VitaminK₂ on breast cancer based on the FDA Adverse Event Reporting System (FAERS)

○Shinsuke Miyazawa¹, Yoshihiro Uesawa² (1. Department of Community Health Care and Sciences, Meiji Pharmaceutical University, 2. Department of Medical Molecular Informatics, Meiji Pharmaceutical University)

[29P-am395S] Utilizing ChatGPT for analyzing adverse effect databases

○Tomoya Komasaka¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

[29P-am396S] Construction and Evaluation of an Ames Predictive Model through the Ensemble of Molecular Image Recognition and Molecular Descriptors

○Yuma Iwashita¹, Yoshihiro Uesawa¹ (1. Meiji Pharmaceutical University)

[29P-am397S] Analysis of predicted mutagenicity and associated adverse effects using the FAERS database

○Koki Shishido¹, Yoshihiro Uesawa¹ (1. Meiji Pharmaceutical University)

[29P-am398] The thinking processes of pharmacy pharmacists in searching for information to solve problems: A qualitative study

○Nobuhiro Inoue¹, Moeka Takagi¹, Koji Kawano¹, Rie Yamauchi¹, Shuji Ohno¹, Hajime Kubo¹, Takayuki Matsumoto¹, Kazunori Asai¹ (1. Hoshi Univ.)

[29P-am399S] Analysis of Relationship between Drug Structure and Adverse Drug Event in the Japanese Adverse Drug Event Report (JADER) Database

○Mana Yamaguchi¹, Satoshi Fukushima¹, Koji Ogata¹ (1. Fac. Pharm. Sci., Sanyo-Onoda City Univ.)

[29P-am400S] A comparative safety study of antiplatelet monotherapy with aspirin and ADP receptor P2Y12 inhibitor versus combination therapy in patients undergoing coil embolization

○Yuuri Nakamura¹, Shinobu Imai², Hiroshi Magara¹, Takuaki Tani², Anna Kiyomi¹, Munetoshi Sugiura¹, Kiyohide Fushimi³ (1. Department of Drug Safety and Risk Management,School of Pharmacy,Tokyo University of Pharmacy and Life Sciences, 2. Department of Pharmacoepidemiology, Showa University Graduate School of Pharmacy, 3. Department of Health Policy and Informatics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University)

[29P-am401S] Factors associated with hypertension of patients undergoing bevacizumab chemotherapy: a retrospective cohort study using claims data.

○Chihiro Nakamura¹, Shinobu Imai², Anna Kiyomi¹, Munetoshi Sugiura¹ (1. Department of Drug Safety and Risk Management,School of Pharmacy,Tokyo University of Pharmacy and Life Sciences, 2. Department of Pharmacoepidemiology, Showa University Graduate School of Pharmacy)

[29P-am402S] Comparison and analysis of side effects generated by ChatGPT and Kusuri-no-Shiori (Drug Information Sheet)

○Mai Nagasawa¹, Aoi Sekimoto¹, Makoto Matsuura¹ (1. Sch.Pharm.Iwate Med.Univ.)

[29P-am403S] Evaluation of contraindicated drugs in pregnant and lactating women generated by ChatGPT

○Aoi Sekimoto¹, Mai Nagasawa¹, Makoto Matsuura¹ (1. Sch.Pharm.Iwate Med.Univ.)

[29P-am404S] Analysis of venous thromboembolism in patients treated with Janus kinase inhibitors using Japanese Adverse Drug Event Report database (JADER)

○Sayaka Aisu¹, Tae Maeshima¹, Naoki Ohkura¹, Machiko Watanabe¹, Fumio Itagaki¹ (1. Faculty of Pharma-Science, Teikyo University)

[29P-am405] Analysis of DILI and DI-ILD from crude drugs in kampo medicines: a comprehensive study using the Japanese adverse drug event report database

○Kyosuke Kimura¹, Mami Kikegawa^1,2, Yusuke Kan^1,3, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ., 2. Yokohama Univ. Pharm., 3. Nanohana Pharmacy)

[29P-am406S] Impact of Adverse Event Reporting of COVID-19 Vaccine on Data Analysis Using JADER

○Yuto Kosaka¹, Daisuke Yamane¹, Tetsuya Shimoyama¹, Kunihiko Itoh¹, Michiya Kobayashi¹ (1. Sch. Pharm. Sci., Health Sci. Univ. of Hokkaido)

[29P-am407S] Comprehensive analysis of antineoplastic drugs with potential association to pneumothorax, based on the FAERS database

○Makoto Kiuchi¹, Yoshihiro Uesawa¹ (1. Meiji Pharm. Univ.)

[29P-am408] Exploring safety information on Lacrimal disorders induced by anticancer drugs: disproportionality analysis using the Japanese adverse drug event report database

○Yusuke Kan^1,2,3, Yoshihiro Uesawa³ (1. Nanohana Pharmacy, 2. Medical System Network, 3. Meiji Pharm. Univ.)

[29P-am409] Efforts by pharmacists to promote proper use of Andexanet Alpha Intravenous Injection

○Mizuki Matsumoto¹, Kozue Nagasawa¹, Hiroki Ota¹, Seichi Shiozi¹ (1. Matsudo City General Hospital)

[29P-am410] Evaluation of remote video on how to use eye drops
- Exploration of eye drop instruction interval using single-blind test –

○Hiroaki IKEDA¹, Tomohisa Kato¹, Ryunosuke Takushi¹, Taketo Ohe¹, Mayu Kaneko¹, Shiho Takagishi¹, Akira Nakatsuma¹, Hitoshi Houchi¹, Naomi Iihara¹, Tetsushi Kawazoe¹, Kumiko Mori¹, Junko Ikeda² (1. Kagawa school of pharmaceutical sciences, Tokushima Bunri University, 2. Towany pharmacy)

[29P-am411] The Utility of New Drug Information Provision from the Drug Information Office: An Evaluation via Clinical Pharmacists' Medication Records

○Hirotoshi Fujita¹, Ayaka Iwabuchi¹, Syuhei Satake¹, Yoshifumi Niinuma¹, Masami Tenma¹ (1. Dept. Pharm., Teine Keijinkai Hosp.)

[29P-am412] An exploratory study of the interventions and outcomes of tracing reports received from community pharmacies surrounding our hospital.

○Misa Fujii¹, Yasukata Ohashi¹, Masato Komuro¹, Junichi Masuda¹, Takahiro Nishimura¹ (1. Department of Pharmacy,National Center for Global Health and Medicine)

[29P-am413] Questionnaire survey on expectations and concerns among healthcare workers for introducing long-acting Cabotegravir and Rilpivirine injections

○Suzuna Kimura¹, Mizuki Kobayashi¹, Koji Nagashima¹, Junichi Masuda¹, Koji Watanabe², Hiroyuki Gatanaga², Takahiro Nishimura¹ (1. Department of pharmacy, National Center for Global Health and Medicine, 2. AIDS Clinical Center, National Center for Global Health and Medicine)

[29P-am414] Association between antiretroviral therapy and new-onset of hyperuricemia in treatment-naïve patients with human immunodeficiency virus

○Taichi Muramatsu¹, Koji Nagashima¹, Risa Suzuki¹, Yasukata Ohashi¹, Junichi Masuda¹, Koji Watanabe², Katsuji Teruya², Hiroyuki Gatanaga², Takahiro Nishimura ¹ (1. Department of Pharmacy, National Center for Global Health and Medicine, 2. AIDS Clinical Center, National Center for Global Health and Medicine)

Session information

[29P-am] Clinical Pharmacy

Authentication